NASDAQ:GLYC
$1.40
(
-0.709%
)
Tuesday, 28th Mar 2023
GlycoMimetics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.21 | $1.72 | Tuesday, 28th Mar 2023 GLYC stock ended at $1.40. This is 0.709% less than the trading day before Monday, 27th Mar 2023. During the day the stock fluctuated 5.88% from a day low at $1.36 to a day high of $1.44. |
| 90 days | $1.21 | $4.16 | |
| 52 weeks | $0.510 | $4.16 |
Historical GlycoMimetics prices
| Date | Open | High | Low | Close | Volume |
| 2023-03-28 | $1.37 | $1.44 | $1.36 | $1.40 | 273 659 |
| 2023-03-27 | $1.39 | $1.44 | $1.36 | $1.41 | 206 039 |
| 2023-03-24 | $1.38 | $1.42 | $1.35 | $1.39 | 161 219 |
| 2023-03-23 | $1.41 | $1.44 | $1.35 | $1.40 | 214 796 |
| 2023-03-22 | $1.46 | $1.46 | $1.38 | $1.38 | 198 111 |
| 2023-03-21 | $1.44 | $1.49 | $1.43 | $1.46 | 222 330 |
| 2023-03-20 | $1.39 | $1.45 | $1.38 | $1.44 | 139 516 |
| 2023-03-17 | $1.48 | $1.48 | $1.38 | $1.40 | 376 768 |
| 2023-03-16 | $1.49 | $1.53 | $1.42 | $1.48 | 320 369 |
| 2023-03-15 | $1.48 | $1.52 | $1.43 | $1.49 | 541 214 |
| 2023-03-14 | $1.45 | $1.57 | $1.44 | $1.55 | 603 688 |
| 2023-03-13 | $1.25 | $1.49 | $1.21 | $1.45 | 802 632 |
| 2023-03-10 | $1.33 | $1.35 | $1.26 | $1.31 | 628 664 |
| 2023-03-09 | $1.49 | $1.54 | $1.33 | $1.33 | 825 327 |
| 2023-03-08 | $1.48 | $1.50 | $1.43 | $1.47 | 503 807 |
| 2023-03-07 | $1.51 | $1.56 | $1.42 | $1.46 | 1 383 484 |
| 2023-03-06 | $1.57 | $1.61 | $1.45 | $1.48 | 1 221 636 |
| 2023-03-03 | $1.55 | $1.63 | $1.52 | $1.56 | 494 567 |
| 2023-03-02 | $1.54 | $1.55 | $1.51 | $1.51 | 744 552 |
| 2023-03-01 | $1.58 | $1.70 | $1.54 | $1.56 | 1 034 367 |
| 2023-02-28 | $1.55 | $1.67 | $1.52 | $1.54 | 1 172 000 |
| 2023-02-27 | $1.69 | $1.72 | $1.58 | $1.62 | 1 273 183 |
| 2023-02-24 | $1.71 | $1.77 | $1.67 | $1.69 | 997 297 |
| 2023-02-23 | $1.80 | $1.83 | $1.71 | $1.71 | 1 746 673 |
| 2023-02-22 | $1.85 | $1.85 | $1.70 | $1.78 | 1 367 202 |
| 2023-02-21 | $1.91 | $1.96 | $1.82 | $1.92 | 1 707 335 |
| 2023-02-17 | $1.79 | $1.88 | $1.62 | $1.88 | 2 279 950 |
| 2023-02-16 | $1.53 | $1.91 | $1.50 | $1.82 | 8 397 155 |
| 2023-02-15 | $2.27 | $2.33 | $1.45 | $1.52 | 14 632 778 |
| 2023-02-14 | $3.78 | $4.16 | $3.67 | $4.05 | 2 178 774 |
| 2023-02-13 | $3.51 | $3.78 | $3.38 | $3.78 | 1 436 159 |
| 2023-02-10 | $3.26 | $3.54 | $3.22 | $3.48 | 1 348 237 |
| 2023-02-09 | $3.17 | $3.30 | $3.00 | $3.26 | 4 860 467 |
| 2023-02-08 | $3.42 | $3.55 | $3.14 | $3.18 | 1 310 265 |
| 2023-02-07 | $3.06 | $3.34 | $2.93 | $3.34 | 6 951 547 |
| 2023-02-06 | $3.15 | $3.15 | $3.02 | $3.05 | 428 668 |
| 2023-02-03 | $3.03 | $3.12 | $3.00 | $3.09 | 380 112 |
| 2023-02-02 | $3.10 | $3.12 | $2.97 | $3.03 | 733 022 |
| 2023-02-01 | $2.98 | $3.12 | $2.92 | $3.09 | 734 653 |
| 2023-01-31 | $2.87 | $3.02 | $2.85 | $2.91 | 793 161 |
| 2023-01-30 | $3.42 | $3.42 | $2.85 | $2.90 | 1 610 007 |
| 2023-01-27 | $3.48 | $3.60 | $3.19 | $3.39 | 1 458 974 |
| 2023-01-26 | $3.11 | $3.35 | $3.00 | $3.35 | 4 578 627 |
| 2023-01-25 | $3.30 | $3.48 | $3.05 | $3.10 | 2 339 315 |
| 2023-01-24 | $2.90 | $3.22 | $2.87 | $3.17 | 921 663 |
| 2023-01-23 | $2.60 | $2.88 | $2.60 | $2.87 | 945 923 |
| 2023-01-20 | $2.57 | $2.70 | $2.53 | $2.56 | 520 674 |
| 2023-01-19 | $2.66 | $2.74 | $2.55 | $2.55 | 509 223 |
| 2023-01-18 | $2.88 | $2.99 | $2.66 | $2.69 | 569 209 |
| 2023-01-17 | $3.06 | $3.07 | $2.79 | $2.88 | 688 614 |
About GlycoMimetics
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
